
Digital Diabetes Management Market Report 2026
Global Outlook – By Product And Service (Devices, Application, Data Management Software And Platforms, Services ), By Device Type (Handheld Devices, Wearable Devices ), By End User (Self Or Home Healthcare, Hospitals And Specialty Diabetes Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Digital Diabetes Management Market Overview
• Digital Diabetes Management market size has reached to $19.19 billion in 2025 • Expected to grow to $58.13 billion in 2030 at a compound annual growth rate (CAGR) of 24.8% • Growth Driver: Rising Diabetes Prevalence Fuels Demand For Digital Diabetes Management Solutions • Market Trend: Advanced Implantable Devices Enhance Continuous Health Tracking • North America was the largest region in 2025 and Western Europe is the fastest growing region.What Is Covered Under Digital Diabetes Management Market?
Digital diabetes management refers to using electronic medical solutions to monitor, analyze, and manage diabetics remotely. People with diabetes or those who are at risk of developing it can improve their health outcomes by successfully managing their condition on their own with the help of digital diabetes management. The main types of products and services in digital diabetes management are devices, application, data management software & platforms, services. A data management platform (DMP) is a piece of software that collects and manages data. They enable companies to create audience segments that can then be utilized to target certain individuals and settings in online advertising campaigns. The different types of devices include handheld devices, wearable devices and used in various sectors such as self or home healthcare, hospitals and specialty diabetes clinics, others.
What Is The Digital Diabetes Management Market Size and Share 2026?
The digital diabetes management market size has grown exponentially in recent years. It will grow from $19.19 billion in 2025 to $23.99 billion in 2026 at a compound annual growth rate (CAGR) of 25.0%. The growth in the historic period can be attributed to rising global diabetes burden, limited access to continuous clinical care, growth of smartphone usage, increasing demand for self-management tools, expansion of digital health solutions.What Is The Digital Diabetes Management Market Growth Forecast?
The digital diabetes management market size is expected to see exponential growth in the next few years. It will grow to $58.13 billion in 2030 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to increasing ai adoption in diabetes care, expansion of remote patient monitoring, rising telehealth acceptance, integration with electronic health records, demand for personalized diabetes management. Major trends in the forecast period include rapid adoption of remote diabetes monitoring platforms, integration of AI-based glucose analytics, expansion of mobile diabetes management applications, increasing use of wearable diabetes devices, growth of telemedicine-based diabetes care.Global Digital Diabetes Management Market Segmentation
1) By Product And Service: Devices, Application, Data Management Software And Platforms, Services 2) By Device Type: Handheld Devices, Wearable Devices 3) By End User: Self Or Home Healthcare, Hospitals And Specialty Diabetes Clinics, Other End Users Subsegments: 1) By Devices: Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGM), Insulin Pumps, Smart Insulin Pens, Diabetes Testing Strips 2) By Application: Diabetes Management Apps, Lifestyle And Diet Management Apps, Glucose Tracking Apps, Insulin Dose Adjustment Apps, Exercise And Activity Tracking Apps 3) By Data Management Software And Platforms: Cloud-Based Diabetes Management Platforms, Data Analytics Platforms, Electronic Health Record (EHR) Integrated Systems, Patient Management Software, Remote Monitoring Software 4) By Services: Telemedicine And Virtual Consultation Services, Remote Monitoring Services, Diabetes Education Services, Diabetes Coaching And Support Services, Clinical Decision Support ServicesWhat Is The Driver Of The Digital Diabetes Management Market?
The increasing prevalence of diabetes is expected to propel the growth of the digital diabetes-management market. Diabetes refers to a metabolic condition characterised by elevated blood glucose levels, most commonly type 2, which impairs the body’s ability to use or produce insulin. The prevalence of diabetes is surging due to the growing rates of obesity, which significantly increase insulin resistance and heighten the risk of developing type 2 diabetes. The digital diabetes-management industry is witnessing increased demand as the rapid expansion of diabetes pushes companies to adopt remote monitoring tools, app-based tracking and personalised digital coaching to help individuals manage their condition more effectively. For instance, in June 2024, according to the NHS England, a UK-based government agency, the number of individuals under the age of 40 at risk of type 2 diabetes has risen by nearly 25% during the same period, increasing from 173,166 in 2022 to 216,440 in 2023. Therefore, The increasing prevalence of diabetes is driving the demand for digital diabetes management industry.Key Players In The Global Digital Diabetes Management Market
Major companies operating in the digital diabetes management market are Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.Global Digital Diabetes Management Market Trends and Insights
Major companies operating in the digital diabetes management market are focusing on developing advanced solutions, such as long-term implantable continuous glucose monitoring (CGM) systems, to reduce patient burden, enhance real-time glucose monitoring, and improve overall diabetes management. Long-term implantable CGM systems refer to devices that are inserted under the skin and continuously monitor glucose levels for extended periods, providing reliable data without frequent sensor replacements, unlike traditional short-term CGMs. For instance, in September 2024, Senseonics Holdings, Inc., a US-based medical technology company, received FDA clearance for Eversense 365, the world’s first fully implantable CGM sensor with a 365-day lifespan. Designed for people with type 1 and type 2 diabetes aged 18 and older, the system transmits glucose readings every five minutes to a mobile app, requires only weekly calibration after the initial two weeks, and features a removable transmitter. This long-term solution minimizes life disruption, reduces sensor replacements, and supports integration with automated insulin delivery (AID) systems, offering a more seamless and accurate approach to digital diabetes management.What Are Latest Mergers And Acquisitions In The Digital Diabetes Management Market?
In May 2023, Medtronic PLC, an Ireland-based medical technology company, acquired EOFLOW Co., Ltd. for $738 million. With this acquisition, Medtronic aims to establish an advanced closed-loop system for more automated diabetes management by combining tubeless devices with their continuous glucose monitors and meal-detection algorithm. EOFLOW Co., Ltd. is a South Korea-based digital and smart wearable diabetes management solutions provider.Regional Outlook
North America was the largest region in the digital diabetes management market in 2025. Western Europe was the second largest region in the digital diabetes management market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Digital Diabetes Management Market?
The digital diabetes management market consists of revenue generated by the companies offering devices and services that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patients' blood glucose levels and controlling their conditions. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Digital Diabetes Management Market Report 2026?
The digital diabetes management market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital diabetes management industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Digital Diabetes Management Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $23.99 billion |
| Revenue Forecast In 2035 | $58.13 billion |
| Growth Rate | CAGR of 25.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product And Service, Device Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
